Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Clinical experience in the treatment of motor fluctuations in Parkinson's disease. Delphi consensus of a group of experts in movement disorders].
Rodríguez-Sanz A, Peña-Llamas E, Alonso-Cánovas A, Alonso-Frech FA, Borrue-Fernández C, Catalán MJ, Fanjul-Arbós S, García-Cobos E, García-Ramos R, García Ruiz-Espiga P, Herreros-Rodríguez J, Kurtis-Urra M, López-Lozano JJ, López-Manzanares L, Martínez-Castrillo JC, Martínez-Fernández R, Mata M, Pérez-Sánchez JR, Posada IJ, Rojo A, Romero-Muñoz JP, Ruiz-Huete C, Sánchez-Alonso MP, Vivancos-Matellano F, En Representación Del Grupo de Trastornos Del Movimiento de la Asociación Madrileña de Neurología ERDGTDMAMN. Rodríguez-Sanz A, et al. Among authors: vivancos matellano f. Rev Neurol. 2020 Dec 1;71(11):407-420. doi: 10.33588/rn.7111.2020088. Rev Neurol. 2020. PMID: 33205387 Free article. Spanish.
Validation of the OPTIMIPARK Questionnaire: A Tool to Optimize Treatment in Parkinson's Disease.
Máñez-Miró JU, Vivancos-Matellano F, Alonso-Frech F, Vela-Desojo L, López-Ariztegui N, López-Manzanares L, Balaguer E, Martínez-Castrillo JC, Herrero-Infante Y, Gasca-Salas C, Morales-Casado MI, Casas E, Hernández A, Pareés I, Tegel-Ayuela I, Martínez-Fernández R, Martinez-Martin P. Máñez-Miró JU, et al. Among authors: vivancos matellano f. Mov Disord Clin Pract. 2022 Oct 18;9(8):1085-1093. doi: 10.1002/mdc3.13581. eCollection 2022 Nov. Mov Disord Clin Pract. 2022. PMID: 36339297 Free PMC article.
[Guidelines for the treatment of child spasticity using botulinum toxin].
Pascual-Pascual SI, Herrera-Galante A, Póo P, García-Aymerich V, Aguilar-Barberà M, Bori-Fortuny I, García-Ruiz PJ, Garreta-Figuera R, Lanzas-Melendo G, de Miguel-León I, Miquel-Rodríguez F, Vivancos-Matellano F; Grupo Español de Espasticidad. Pascual-Pascual SI, et al. Rev Neurol. 2007 Mar 1-15;44(5):303-9. Rev Neurol. 2007. PMID: 17342682 Free article. Spanish.
Spanish expert consensus on the use of safinamide in Parkinson's disease.
Valldeoriola F, Grandas F, Arbelo JM, Blázquez Estrada M, Calopa Garriga M, Campos-Arillo VM, Garcia Ruiz PJ, Gómez Esteban JC, Leiva Santana C, Martínez Castrillo JC, Mir P, Salvador Aliaga A, Vivancos Matellano F, Yáñez Baña RM. Valldeoriola F, et al. Among authors: vivancos matellano f. Neurologia (Engl Ed). 2018 Jul 30:S0213-4853(18)30172-5. doi: 10.1016/j.nrl.2018.04.007. Online ahead of print. Neurologia (Engl Ed). 2018. PMID: 30072274 Free article. English, Spanish.
21 results